To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In recent months, Biogen has ...
If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Here's a roundup of Boston-area ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM ESTCompany ParticipantsChristopher Viehbacher - President, CEO ...
Biogen plans to beef up its early-stage immunology pipeline by handing over $70 million in upfront cash for the rights to Vanqua Bio’s preclinical C5aR1 antagonist. Biogen described C5aR1 as a ...
Biogen recorded declining sales for Spinraza in each of the four quarters of 2025, but the Massachusetts drugmaker sees positive signs with the recent launch of its high-dose (HD) version of the ...
CAMBRIDGE, Mass. — Biogen on Tuesday held a ceremonial groundbreaking of its 16-story headquarters in Kendall Square, ushering in the latest phase of the neighborhood’s transformation from “Nowhere ...
Biogen (NASDAQ:BIIB) said that it has agreed to acquire Alcyone Therapeutics, a company based in Massachusetts. The deal involves an upfront payment of $85M, along with additional milestone payments ...
BOSTON — On the first Monday in March, Michel Vounatsos, chief executive of the drug company Biogen, appeared in good spirits. The company’s new Alzheimer’s drug was showing promise after years of ...
Biogen has given Alcyone Therapeutics a starring role in its drug delivery strategy, paying $85 million to buy the biotech and take control of an implant for getting medicines into the spinal canal.
Despite possessing a solid data package on the potential of high-dose Sprinraza in spinal muscular atrophy (SMA), Biogen will now need to revise its application if it hopes to secure an FDA nod. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results